CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 43 filers reported holding CATALYST BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $722,000 | -1.6% | 175,751 | +3.7% | 0.07% | -10.8% |
Q2 2021 | $734,000 | +460.3% | 169,535 | +553.8% | 0.08% | +277.3% |
Q1 2021 | $131,000 | +63.8% | 25,932 | +105.2% | 0.02% | +69.2% |
Q4 2020 | $80,000 | -65.5% | 12,635 | -62.9% | 0.01% | -51.9% |
Q4 2019 | $232,000 | -22.4% | 34,047 | -16.0% | 0.03% | -18.2% |
Q2 2019 | $299,000 | -91.3% | 40,526 | -87.3% | 0.03% | -82.6% |
Q3 2018 | $3,449,000 | +88.1% | 319,915 | +103.6% | 0.19% | +108.8% |
Q2 2018 | $1,834,000 | – | 157,145 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |